Daily tablet shows promise in treating achondroplasia in children

A promising daily tablet is effective at increasing height and improving proportional limb growth in children with achondroplasia, the most common form of dwarfism, according to a new study.

Charles River’s CDMO revenue rise; Catalent lays off 300 staffers; Biogen’s idle capacity

Charles River’s overall manufacturing business saw a 9.5% decrease in revenue in the last quarter of 2023 with $191.9 million, versus $212.1 million in the

February 16, 2024

AI Diagnoses Deadly Disease; Radiology’s New AI Guidance; WHO Tackles LMMs

Welcome to MedAI Roundup, highlighting the latest news and research in healthcare-related artificial intelligence each month. Researchers at Children’s National Hospital in Washington, D.C., have

January 26, 2024

Terns Pharmaceuticals touts mid-stage success for NASH drug, stock falls

Terns Pharmaceuticals said a high dose of its experimental oral NASH treatment helped reduce liver fat in a Phase IIa trial. The Foster City, CA-based

August 10, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.